newsfilter
← Latest News
GlobeNewswire·

Evaxion expands AI-Immunology™ platform into autoimmune diseases

Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focusIn future, Evaxion's proprietary AI-Immunology™ platform will enable the discovery and development of drug candidates